✦ LIBER ✦

The benefits of early treatment in rheumatoid arthritis: Confounding by indication, and the issue of timing

✍ Scribed by Robert B. M. Landewé

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 57 KB
Volume: 48
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.10732

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The benefit of low-dose glucocorticoid t

The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris

✍ Johannes W. G. Jacobs; Maarten Boers; John R. Kirwan; Johannes W. J. Bijlsma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Diet in the treatment of rheumatoid arth

Diet in the treatment of rheumatoid arthritis

✍ Dr Morris Ziff 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 3 views

What rheumatologist has not been asked about the role of diet ifi the treatment of rheumatoid arthritis? Who among us has not responded that there is no evidence that diet treatment works? Editors are generally reluctant to publish negative studies, but the paper by Panush et al in this month's Arth

Timing of Pregnancy in Relation to the O

Timing of Pregnancy in Relation to the Onset of Rheumatoid Arthritis

✍ Alan Silman; April Kay; Paul Brennan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 2 views

Evidence for the benefit of aerobic and

Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis

✍ Stenström, Christina H. ;Minor, Marian A. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Oral collagen in the treatment of rheuma

Oral collagen in the treatment of rheumatoid arthritis

✍ Joachim R. Kalden; Joachim Sieper 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

Emerging therapies in the treatment of r

Emerging therapies in the treatment of rheumatoid arthritis

✍ Jinqi Liu; Huseyin Mehmet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract Rheumatoid arthritis (RA) is an autoimmune disease with a significant morbidity defined by marked destruction and deformity of joints. It is characterized by autoantibody production, synovial inflammation, and erosion of the cartilage and bone. The current first‐line treatment for RA is